Delivery Order SPE2DB22D2214-SPE2DB25FS6CP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for Progesterone 100 mg capsules (100 count) valued at $2,476.27. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,684.10 under firm fixed pricing terms, with an ultimate completion date of August 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Progesterone 200 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $7,627.49, represents a non-competitive set-aside award and is scheduled for completion by August 6, 2025. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Department's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units, with a ceiling value of $1,519.84. This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,969.07 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for Progesterone 200 mg capsules (100 count) with a ceiling value of $23,942.71. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. The contract is expected to...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.30 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on August 12, 2025, with a contract ceiling value of $1,669.70. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 13, 2025. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6CPDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with a ceiling value of $10,890.90 and an ultimate completion date of August 13, 2025. The award represents a pharmaceutical supply fulfillment under the federal medical procurement framework supporting military healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle active through December 2026. The IDC enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's established role as a major federal pharmaceutical vendor, demonstrated through multiple competitively awarded contracts across diverse therapeutic domains, positions the company as a critical supplier for military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/12/25 |